New drug FT1 tested for safety in healthy volunteers
NCT ID NCT06610487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of a new drug called FT1 in 60 healthy adults aged 18 to 45. Participants received either FT1 or a placebo injection. The goal was to see if FT1 is safe and how the body processes it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA CAUSED BY DRUG (DISORDER) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bishan Hospital of Chongqing
Chongqing, Chongqing Municipality, 402760, China